ROCKWELL MEDICAL, INC. Investment Income, Interest and Dividend
ROCKWELL MEDICAL, INC. (RMTI) reported Investment Income, Interest and Dividend of $216.07 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2017-05-09
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for the quarter ending 2017-03-31 was $216.07K, a 15.82% increase year-over-year.
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for the quarter ending 2016-12-31 was $207.91K, a 29.10% decline year-over-year.
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for the quarter ending 2016-09-30 was $188.85K, a 20.54% increase year-over-year.
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for the quarter ending 2016-06-30 was $227.02K, a 92.14% increase year-over-year.
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for fiscal 2016 was $810.34K, a 18.84% increase from fiscal 2015.
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for fiscal 2015 was $681.88K, a 76.53% increase from fiscal 2014.
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for fiscal 2014 was $386.26K, a 293.73% increase from fiscal 2013.
- ROCKWELL MEDICAL, INC. investment income, interest and dividend for fiscal 2013 was $98.10K, a 59.38% decline from fiscal 2012.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 12 month |
|---|---|---|---|---|
| 2017-03-31 | $216.07K 10-Q · filed 2017-05-09 | $423.98K derived: sum of 2 quarters · filed 2017-05-09 | $612.83K derived: sum of 3 quarters · filed 2017-05-09 | $839.85K derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | $207.91K 10-K · filed 2017-03-15 | $396.76K derived: sum of 2 quarters · filed 2017-03-15 | $623.78K derived: sum of 3 quarters · filed 2017-03-15 | $810.34K 10-K · filed 2017-03-15 |
| 2016-09-30 | $188.85K 10-K · filed 2017-03-15 | $415.87K derived: sum of 2 quarters · filed 2017-03-15 | $602.43K 10-Q · filed 2016-11-07 | $895.67K derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-06-30 | $227.02K 10-K · filed 2017-03-15 | $413.58K 10-Q · filed 2016-08-09 | $706.82K derived: sum of 3 quarters · filed 2017-05-09 | $863.49K derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-03-31 | $186.56K 10-Q · filed 2017-05-09 | $479.80K derived: sum of 2 quarters · filed 2017-05-09 | $636.47K derived: sum of 3 quarters · filed 2017-05-09 | $754.62K derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $293.24K 10-K · filed 2017-03-15 | $449.91K derived: sum of 2 quarters · filed 2017-03-15 | $568.06K derived: sum of 3 quarters · filed 2017-03-15 | $681.88K 10-K · filed 2017-03-15 |
| 2015-09-30 | $156.67K 10-K · filed 2017-03-15 | $274.82K derived: sum of 2 quarters · filed 2017-03-15 | $388.64K 10-Q · filed 2016-11-07 | $575.78K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $118.15K 10-K · filed 2017-03-15 | $231.97K 10-Q · filed 2016-08-09 | $419.11K derived: sum of 3 quarters · filed 2017-03-15 | $474.37K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $113.81K 10-K · filed 2017-03-15 | $300.96K derived: sum of 2 quarters · filed 2017-03-15 | $356.22K derived: sum of 3 quarters · filed 2017-03-15 | $425.86K derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $187.14K 10-K · filed 2016-02-29 | $242.41K derived: sum of 2 quarters · filed 2016-02-29 | $312.04K derived: sum of 3 quarters · filed 2016-02-29 | $386.26K 10-K · filed 2017-03-15 |
| 2014-09-30 | $55.26K 10-K · filed 2016-02-29 | $124.90K derived: sum of 2 quarters · filed 2016-02-29 | $199.11K 10-Q · filed 2015-11-09 | $268.43K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $69.63K 10-K · filed 2016-02-29 | $143.85K 10-Q · filed 2015-08-04 | $213.16K derived: sum of 3 quarters · filed 2016-02-29 | $226.71K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $74.22K 10-K · filed 2016-02-29 | $143.53K derived: sum of 2 quarters · filed 2016-02-29 | $157.08K derived: sum of 3 quarters · filed 2016-02-29 | $161.64K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $69.32K 10-K · filed 2015-03-03 | $82.86K derived: sum of 2 quarters · filed 2015-03-03 | $87.43K derived: sum of 3 quarters · filed 2015-03-03 | $98.10K 10-K · filed 2016-02-29 |
| 2013-09-30 | $13.55K 10-K · filed 2015-03-03 | $18.11K derived: sum of 2 quarters · filed 2015-03-03 | $28.78K 10-Q · filed 2014-11-10 | $39.82K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $4.57K 10-K · filed 2015-03-03 | $15.24K 10-Q · filed 2014-07-31 | $26.27K derived: sum of 3 quarters · filed 2015-03-03 | $68.57K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $10.67K 10-K · filed 2015-03-03 | $21.71K derived: sum of 2 quarters · filed 2015-03-03 | $64.00K derived: sum of 3 quarters · filed 2015-03-03 | $141.09K derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $11.03K 10-K · filed 2014-03-07 | $53.33K derived: sum of 2 quarters · filed 2014-03-07 | $130.42K derived: sum of 3 quarters · filed 2014-03-07 | $241.52K 10-K · filed 2015-03-03 |
| 2012-09-30 | $42.30K 10-K · filed 2014-03-07 | $119.39K derived: sum of 2 quarters · filed 2014-03-07 | $230.48K 10-Q · filed 2013-11-05 | $233.92K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | $77.09K 10-K · filed 2014-03-07 | $188.19K 10-Q · filed 2013-08-01 | $191.62K derived: sum of 3 quarters · filed 2014-03-07 | $268.73K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $111.10K 10-K · filed 2014-03-07 | $114.53K derived: sum of 2 quarters · filed 2014-03-07 | $191.64K derived: sum of 3 quarters · filed 2014-03-07 | $269.18K derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | $3.43K 10-K · filed 2013-03-18 | $80.54K derived: sum of 2 quarters · filed 2013-03-18 | $158.08K derived: sum of 3 quarters · filed 2013-03-18 | $244.05K 10-K · filed 2014-03-07 |
| 2011-09-30 | $77.11K 10-K · filed 2013-03-18 | $154.65K derived: sum of 2 quarters · filed 2013-03-18 | $240.62K 10-Q · filed 2012-11-09 | $398.19K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $77.54K 10-K · filed 2013-03-18 | $163.51K 10-Q · filed 2012-08-07 | $321.09K derived: sum of 3 quarters · filed 2013-03-18 | $338.34K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $85.97K 10-K · filed 2013-03-18 | $243.54K derived: sum of 2 quarters · filed 2013-03-18 | $260.80K derived: sum of 3 quarters · filed 2013-03-18 | $271.73K derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $157.58K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $174.83K derived: sum of 2 quarters · filed 2013-03-18 | $185.76K derived: sum of 3 quarters · filed 2013-03-18 | $195.22K 10-K · filed 2013-03-18 |
| 2010-09-30 | $17.26K 10-Q · filed 2011-11-04 | $28.18K derived: sum of 2 quarters · filed 2011-11-04 | $37.64K 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $10.93K 10-Q · filed 2011-08-05 | $20.38K 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $5.32K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |